
Sun Pharma Advanced Research Company Shows Strong Short-Term Gains Amid Broader Market Rally
2025-03-24 12:05:18Sun Pharma Advanced Research Company has seen significant short-term gains, outperforming its sector and achieving a notable return over the past five days. While currently above several moving averages, the stock's long-term performance reveals substantial declines over the past year and decade, contrasting with broader market trends.
Read MoreSun Pharma Advanced Research Faces Mixed Technical Signals Amid Recent Stock Performance Surge
2025-03-24 08:01:44Sun Pharma Advanced Research Company (SPARC), a small-cap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 147.75, showing a notable increase from the previous close of 144.50. Over the past week, SPARC has experienced a significant return of 20.12%, outperforming the Sensex, which returned 4.17% in the same period. In terms of technical indicators, the MACD remains bearish on both weekly and monthly charts, while the Relative Strength Index (RSI) shows no signal for either timeframe. The Bollinger Bands indicate a mildly bearish trend on both weekly and monthly scales, and moving averages also reflect a mildly bearish sentiment on a daily basis. The KST is bearish for both weekly and monthly evaluations, while the Dow Theory presents a mildly bullish outlook on a weekly basis, contrasting wi...
Read More
Sun Pharma Advanced Research Company Shows Short-Term Gains Amid Long-Term Challenges
2025-03-20 13:35:18Sun Pharma Advanced Research Company has seen a notable increase in stock performance, gaining 10.01% on March 20, 2025, and achieving consecutive gains over three days. Despite recent short-term success, the company's year-to-date performance remains down significantly compared to broader market trends.
Read More
Sun Pharma Advanced Research Company Shows Signs of Recovery Amid Ongoing Market Challenges
2025-03-18 15:15:50Sun Pharma Advanced Research Company (SPARC) saw a significant increase in its stock price today, reversing a five-day decline. Despite this uptick, SPARC's performance over the past week and month remains negative, with substantial drops noted over the past three months and year, indicating ongoing market challenges.
Read More
Sun Pharma Advanced Research Company Shows Strong Short-Term Gains Amid Long-Term Challenges
2025-03-07 10:15:47Sun Pharma Advanced Research Company has seen a notable increase today, outperforming its sector significantly. The stock has shown a positive trend over the past two days, while intraday highs reflect a substantial rise. Despite today's gains, the company has faced considerable declines over the past year.
Read More
Sun Pharma Advanced Research Company Shows Signs of Recovery Amid Broader Market Challenges
2025-03-04 14:35:17Sun Pharma Advanced Research Company (SPARC) rebounded on March 4, 2025, after six days of decline, reaching an intraday high of Rs 120.6. Despite this uptick, SPARC remains below key moving averages. Meanwhile, the broader market shows mixed signals, with small-cap stocks performing better amid a bearish trend.
Read More
Sun Pharma Advanced Research Faces Significant Stock Volatility Amid Industry Challenges
2025-03-03 10:36:30Sun Pharma Advanced Research Company has hit a new 52-week low, reflecting significant volatility and a cumulative decline over the past six days. The stock is trading below all major moving averages and has experienced a steep year-over-year drop, contrasting sharply with broader market trends.
Read More
Sun Pharma Advanced Research Faces Significant Decline Amid Challenging Market Conditions
2025-02-28 12:35:16Sun Pharma Advanced Research Company has faced notable challenges, with its stock declining significantly today and reaching a new 52-week low. The company has underperformed its sector and experienced high intraday volatility, reflecting ongoing difficulties in the market over the past month.
Read More
Sun Pharma Advanced Research Company Hits 52-Week Low Amid Ongoing Volatility
2025-02-28 09:38:15Sun Pharma Advanced Research Company has hit a new 52-week low of Rs. 119, reflecting significant volatility and a 10.94% decline over the past five days. The stock has underperformed its sector and is trading below key moving averages, indicating ongoing challenges in the small-cap pharmaceuticals market.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Apr-2025 | Source : BSECertificate under Regulation 74(5) of SEBI (DP) Regulations 2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
31-Mar-2025 | Source : BSEPress Release about submission of IND application for SBO-154 to USFDA
Closure of Trading Window
27-Mar-2025 | Source : BSEIntimation regarding closure of trading window
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Sun Pharma Advanced Research Company Ltd has announced 5:116 rights issue, ex-date: 16 Mar 16